Valproic Acid

Valproic Acid

SCHEMBL1311803

CCCC(CCC)C(=O)O.[BiH3]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ALDH5A1

The experimentally established mechanism targets of Valproic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.94
AKR1A1 P14550 1/20 0.94
CHRM3 P20309 1/20 0.94
HTR2A P28223 1/20 0.94
HTR2C P28335 1/20 0.94
ADRA1A P35348 1/20 0.94
HRH1 P35367 1/20 0.94
DRD3 P35462 1/20 0.94
SLC6A3 Q01959 1/20 0.94
HDAC1 Q13547 1/20 0.94
HDAC2 Q92769 1/20 0.94
TDP1 Q9NUW8 1/20 0.94
SLC1A2 P43004 4/20 0.60
SLC1A1 P43005 4/20 0.60
GRIK1 P39086 4/20 0.60
GRIK2 Q13002 4/20 0.60
SLC1A3 P43003 3/20 0.60
CYP3A4 P08684 2/20 0.55
TSHR P16473 2/20 0.55
NFKB1 P19838 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valproic Acid SCHEMBL140241 0.97 CHRM1 (1.00) CHRM1AKR1A1CHRM3HTR2AHTR2C
Valproic Acid SCHEMBL2275 0.97 CHRM1 (1.00) CHRM1AKR1A1CHRM3HTR2AHTR2C
Valproic Acid SCHEMBL1330837 0.97 CHRM1 (1.00) CHRM1AKR1A1CHRM3HTR2AHTR2C
Valproic Acid SCHEMBL139238 0.94 CHRM1 (0.94) CHRM1AKR1A1CHRM3HTR2AHTR2C
Valproic Acid SCHEMBL69795 0.94 CHRM1 (0.94) CHRM1AKR1A1CHRM3HTR2AHTR2C
Valproic Acid SCHEMBL6910916 0.94 CHRM1 (0.94) CHRM1AKR1A1CHRM3HTR2AHTR2C
Valproic Acid SCHEMBL7579608 0.94 CHRM1 (0.94) CHRM1AKR1A1CHRM3HTR2AHTR2C
Valproic Acid SCHEMBL2184648 0.94 CHRM1 (0.94) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL1738242 0.94 CHRM1 (0.94) CHRM1AKR1A1CHRM3HTR2AHTR2C
Valproic Acid SCHEMBL21378840 0.94 CHRM1 (0.94) CHRM1AKR1A1CHRM3HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111329881-A Oral ulcer film and preparation method and application thereof 中国医学科学院北京协和医院 2020-06-26 CN claimed
CN-102326076-B Chemical indicator compositions, indicators and methods 3M INNOVATIVE PROPERTIES CO. (US) 2016-06-01 CN claimed
US-9170245-B2 Chemical indicator composition, indicators and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-10-27 US claimed
EP-2506006-A1 Chemical indicator composition, indicators and methods 3M Innovative Properties Company (US) 2012-10-03 EP claimed
CN-102326076-A Chemical indicator compositions, indicators and methods 3M INNOVATIVE PROPERTIES CO 2012-01-18 CN claimed
US-20110275159-A1 CHEMICAL INDICATOR COMPOSITION, INDICATORS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-11-10 US claimed
EP-2382461-A2 CHEMICAL INDICATOR COMPOSITION, INDICATORS AND METHODS 3M Innovative Properties Company (US) 2011-11-02 EP claimed
WO-2010078422-A2 CHEMICAL INDICATOR COMPOSITION, INDICATORS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-07-08 WO claimed
US-20080020059-A1 COMPOSITIONS AND METHODS FOR TOPICAL TREATMENT OF SKIN INFECTION CHIOU CONSULTING, INC. (US) 2008-01-24 US claimed
CN-101049316-A Application of medical use lithium salt or medical use medication of valproic acid class as medication for treating sclerosis of amyotrophia FENG HONGLIN (CN) 2007-10-10 CN claimed
US-7258875-B2 Compositions and methods for topical treatment of skin infection CHIOU CONSULTING, INC. (US) 2007-08-21 US claimed
US-20050186288-A1 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions CHIOU CONSULTING INC. (US) 2005-08-25 US claimed
WO-2005055927-A2 COMPOSITIONS AND METHODS FOR TOPICAL TREATMENT OF SKIN INFECTION CHIOU CONSULTING INC. (US) 2005-06-23 WO claimed
US-20050123620-A1 Compositions and methods for topical treatment of skin infection CHIOU CONSULTING, INC. 2005-06-09 US claimed
US-11484614-B2 Water-based sterilization indicator composition 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-11-01 US disclosed
CN-108699374-B Water-based sterilization indicator composition 3M创新有限公司 2021-07-06 CN disclosed
EP-2795312-B1 WATER-BASED STERILIZATION INDICATOR COMPOSITION, METHOD FOR ITS PREPARATION AND INDICATOR TAPE 3M INNOVATIVE PROPERTIES CO (US) 2021-02-24 EP disclosed
US-20050123620-A1 Compositions and methods for topical treatment of skin infection CHIOU CONSULTING, INC. 2005-06-09 US disclosed
EP-1531837-A1 COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF APHTHOUS ULCERS AND HERPES SIMPLEX LESIONS Chiou Consulting, Inc. (US) 2005-05-25 EP disclosed
WO-2003103691-A1 COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF APHTHOUS ULCERS AND HERPES SIMPLEX LESIONS CHIOU CONSULTING, INC. (US) 2003-12-18 WO disclosed